LACHINIMOD FOR THE TREATMENT OF PATIENTS WITH RECURRENT-REMITTING MULTIPLE SCLEROSIS (PPRS) WITH HIGH STATUS OF DISABILITY

摘要

The present invention provides a method for treating or reducing impaired walking in a person diagnosed with relapsing-remitting multiple sclerosis (PRRS) and having a high initial assessment of disability using the Kurtzke Expanded Disability Rating Scale (EDSS), which includes periodically administering only to a patient diagnosed with PPRS and having a high An initial assessment of the incapacitation of lakhinimod, effective for treating a patient or reducing impairment of walking. The present invention also provides pharmaceutical compositions and packaging comprising an effective amount of laquinimode for treating a patient patient with a diagnosis of PPRS and having a high initial assessment of EDSS disability.